Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01279876
What this trial is testing

Melatonin in Relapsing-Remitting Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Tehran University of Medical Sciences 25
Large-scale testing (Phase 3)WithdrawnNCT02428218
What this trial is testing

Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-Remitting Multiple SclerosisRelapsing Forms of Multiple Sclerosis
Biogen
Not applicableUnknownNCT05446285
What this trial is testing

Multiple Sclerosis Outcome Determination Evaluating Real Differences After TimE

Who this might be right for
Relapsing Remitting Multiple Sclerosis
NHS Greater Glasgow and Clyde 245
Testing effectiveness (Phase 2)Looking for participantsNCT07517185
What this trial is testing

The HIt HArd and hiT Early in Multiple Sclerosis Trial

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Uppsala University 60
Testing effectiveness (Phase 2)Study completedNCT00067327
What this trial is testing

Treatment of Multiple Sclerosis Using Over the Counter Inosine

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
National Center for Complementary and Integrative Health (NCCIH) 30
Testing effectiveness (Phase 2)Study completedNCT04211740
What this trial is testing

Phase II Clinical Trial of OCH-NCNP1

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive
National Center of Neurology and Psychiatry, Japan 30
Testing effectiveness (Phase 2)Ended earlyNCT03536559
What this trial is testing

Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple SclerosisOptic NeuropathyOptic; Neuritis, With Demyelination
Clene Nanomedicine 73
Not applicableStudy completedNCT03029897
What this trial is testing

E-reporting of Adverse Drug Reactions by Patients in Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University Hospital, Caen 161
Not applicableStudy completedNCT04940065
What this trial is testing

Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen

Who this might be right for
Relapsing-remitting Multiple SclerosisActive Secondary Progressive Multiple Sclerosis
Novartis Pharmaceuticals 367
Large-scale testing (Phase 3)Study completedNCT00340834
What this trial is testing

Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase

Who this might be right for
Multiple Sclerosis
Novartis 1,292
Post-approval studies (Phase 4)UnknownNCT00910598
What this trial is testing

Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Amphia Hospital 60
Not applicableStudy completedNCT01235455
What this trial is testing

Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)Secondary Progressive Multiple Sclerosis (SPMS)
Bayer 10
Testing effectiveness (Phase 2)Study completedNCT02035514
What this trial is testing

Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
Germans Trias i Pujol Hospital 9
Large-scale testing (Phase 3)UnknownNCT00984984
What this trial is testing

Efficacy and Safety of Methylprednisolone Per os Versus IV for the Treatment of Multiple Sclerosis (MS) Relapses

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Rennes University Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT02038049
What this trial is testing

Assess the Effect of a Single Infusion of VAY736 on Disease Activity in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapse Remitting Multiple Sclerosis
Novartis Pharmaceuticals 8
Not applicableStudy completedNCT00675883
What this trial is testing

COMPliance With Avonex® PS in Patients With Relapsing-Remitting MS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 1,000
Not applicableUnknownNCT03787446
What this trial is testing

PET Study in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of British Columbia 9
Large-scale testing (Phase 3)UnknownNCT01464905
What this trial is testing

Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Nuron Biotech Inc. 500
Testing effectiveness (Phase 2)Ended earlyNCT00095329
What this trial is testing

Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
National Institute of Allergy and Infectious Diseases (NIAID) 14
Post-approval studies (Phase 4)Study completedNCT01225289
What this trial is testing

Impact of Vitamin A Supplementation on Immune System in Multiple Sclerosis Patients

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Tehran University of Medical Sciences 36
Next Page